ΡΑΜΖΑ ΔΙΑΜΑΝΤΗ

MD, MRCOphth, FEBO

ΧΕΙΡΟΥΡΓΟΣ ΟΦΘΑΛΜΙΑΤΡΟΣ

RAMZA DIAMANTI

MD, MRCOphth, FEBO

OPHTHALMOLOGIST SURGEON

  • Ελληνικά

Publications

  • Findl O, Fernández J, Diamanti R, Khoramnia R, Kretz F, Carones, Integrating presbyopia-correction into the everyday cataract practice, Eurotimes Jan-Feb 2025
  • Karageorgiou G, Petrou P, Kandarakis S, Rouvas A, Georgalas I, Datseris I, Diamanti R, Papakonstantinou E, Karamaounas A, Datseris I. ANTI-VEGF with PDT VS ANTI-VEGF with MICROPULSE laser for POLYPOIDAL CHOROIDAL VASCULOPATHY: A 12-month retrospective observational study, RETINA The Journal of Retinal and Vitreous Diseases
  • PhD Candidate 2020-2023: Aflibercept intravitreal injection effect on Polypoidal  Choroidal Vasculopathy as monotherapy and in combination with low fluence photodynamic therapy (LF-pdt).
  • Stefanickova J, Cunha-Vaz J, Ulbig M, Pearce I, Fernández-Vega Sanz A, Theodossiadis P, Kodjikian L, Izmailov A Muston D, Vassilev Z, Lamotte B, Tückmantel C, Friedl S, Altemark A, Schwarz HJ, Katz T; POLARIS study investigators. (2018). A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS). Acta Ophthalmol. 96(8):942-949
  • Thrapsanioti Z, Askounis P, Datseris I, Diamanti R, Papathanasiou M, Carinou E. (2017). Eye Lens Radiation Exposure in Greek Interventional Cardiology Article. Radiat Prot Dosimetry 175(3):344-356
  • Liaska A, Petrou P, Georgakopoulos C, Diamanti R, Papaconstantinou D, Kanakis M, and Georgalas I. (2016). β-Thalassemia and ocular implications: a systematic review. BMC Ophthalmol 8(16):102.
  • Ioannis Datseris I, Kontadakis G, Diamanti R, Pallikaris I, Theodossiadis P, and Tsilimbaris M. (2015). Prospective comparison of low-fluence photodynamic therapy combined intravitreal bevacizumab versus bevacizumab monotherapy for choroidal neovascularization in age-related macular degeneration. Semin Ophthalmol 30(2):112-117.
  • Rouvas A, ChatziralliI, Ladas I, Xanthopoulou V, Giannakaki E, Karamboula A, Galanis D, Datseris I, Alonistioti D, Diamanti R, Tsilimbaris M, Chalkia A, Theodossiadis P. (2014). The impact of financial crisis on central serous chorioretinopathy in Greece: is there any correlation? Eur J Ophthalmol 24(4):559-565
  • Evaluating Investigator, RETAIN Study: (2012). A 2-year randomized, single-masked, multicenter, controlled phase IIIb trial assessing th.e efficacy and safety of 0.5 mg ranibizumab in two “treat and extend” Treatment algorithms vs. 0.5 mg ranibizumab as needed in patients with macular oedema and visual impairment secondary to Diabetes Mellitus.
Back to CV